Privi Speciality Chemicals (PRIVISCL) Q4 24/25 earnings summary

Executive summary

• Achieved record quarterly and annual financial performance in FY25, driven by process intensification, yield improvements, and new specialty product launches.

• Plants operated at optimal levels with strong demand for core and co-products; export sales accounted for 70% of annual revenue and 73% in Q4.

• Strategic expansion underway, including successful commissioning of the PRIGIV plant and planned capacity increase by 6,000 MTPA by FY26.

• Sustainability initiatives recognized by EcoWare/EcoVadis Gold rating and improved CDP score, with ongoing efforts to increase green power usage.

• Audited standalone and consolidated financial results for FY25 were approved with unmodified opinions from statutory auditors.

Financial highlights

• Q4 FY25 revenue reached Rs 628.37 Cr, up 28% YoY; EBITDA at Rs 147.42 Cr, up 50% YoY; PAT at Rs 63.98 Cr, up 101% YoY.

• FY25 consolidated revenue was Rs 2,122 Cr, up 19% YoY; EBITDA at Rs 474 Cr, up 37% YoY; PAT at Rs 185 Cr, up from Rs 95 Cr.

• EBITDA margin improved to 23.5% in Q4 and 22.3% for FY25; PAT margin at 8.71% for FY25.

• EPS for FY25 at Rs 47.87, up from Rs 24.43 in FY24.

• Board recommended a final dividend of Rs 5 per equity share for FY25.

Outlook and guidance

• Targeting sustainable EBITDA margins above 20%, with a focus on maintaining above 21%.

• Capacity expansion of 6,000 MTPA expected by March 2026, with capex of Rs 250–300 Cr funded by internal accruals and debt.

• Two new premium products to be launched mid-year, with further launches in FY26–27; new plant expected to break even by FY27.

• Continued emphasis on operational efficiency, sustainability, and strategic collaborations to drive growth.

• Final dividend of Rs 5 per share recommended for FY25, with record date set as July 24, 2025.